Metraipolis › archive › dc_41889f644f8b

Aldosterone Synthase Inhibitors: Emerging Therapeutic Strategies in Resistant Hypertension — Europe PMC PMID:42795360

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42795360
DOI
10.3390/life16091495
License (as archived)
solo-consultazione
Archived
2026-10-15T23:25:22.963Z
SHA-256 of the archived text
1fe081419abe293bf0bbbe33f685ef87bd2809a4c8063178d6c1401b3db943c1
Stable URL of this page
https://metraipolis.com/documento/dc_41889f644f8b

How to cite

Aldosterone Synthase Inhibitors: Emerging Therapeutic Strategies in Resistant Hypertension — Europe PMC PMID:42795360 — Europe PMC (en), https://europepmc.org/article/MED/42795360 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_41889f644f8b (Metraipolis archive dc_41889f644f8b, sha256 1fe081419abe293bf0bbbe33f685ef87bd2809a4c8063178d6c1401b3db943c1)
BibTeX
@misc{dc41889f644f8b,
  title = {Aldosterone Synthase Inhibitors: Emerging Therapeutic Strategies in Resistant Hypertension — Europe PMC PMID:42795360},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42795360},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_41889f644f8b; sha256 1fe081419abe293bf0bbbe33f685ef87bd2809a4c8063178d6c1401b3db943c1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42795360. Agents can read the archived copy with the MCP tool read_document.